Approved GLP-1 Agonists for Weight Loss Currently, there are two GLP-1R agonists approved for the treatment of obesity, Saxenda (liraglutide) and Wegovy (semaglutide) , both developed by Novo Nordisk and approved by the FDA in 2014 and 2021, respectively
For Strength and Power Athletes Strength athletes, bodybuilders, and power-focused competitors can leverage Setria For Sport for: Increased lean mass development when combined with resistance training Enhanced muscle pump and nutrient delivery to working muscles Improved recovery between intense sets Better strength-to-muscle mass correlation Strength athletes should consider daily supplementation with pre-workout doses timed 60 minutes before training sessions
The phase II independent validation cohort (Figure 1B) consisted of 51 men who were receiving chemotherapy (Docetaxel 75 mg m 2 3-weekly, Cabazitaxel 25 mg m 2 3-weekly or Mitoxantrone 12 mg m 2 3-weekly) for mCRPC, who had blood samples obtained prior to commencing chemotherapy and just prior to their second cycle of treatment and were enrolled between April 2009 and September 2012 from hospitals in the PRIMe (Pharmacogenomic Research for Individualized Medicine) network: Sydney Cancer Centre (Royal Prince Alfred Hospital and Concord Hospital), the SAN Clinic, Westmead Hospital and the Mater Misericorde Newcastle Hospital
BPC-157 functions as a free radical scavenger
